Upload Avatar (500 x 500)
Xiuheng Liu
drliuxh@hotmail.com
English, Chinese
Hubei
Wuhan University
Medical School
  • 1979-1984: Bachelor of Clinical Medicine from Hubei Medical College
  • 1984-1987: Master of Surgery from Hubei Medical College
  • 1991-1992: Research Fellow in Urology at Shiga University of Medical Science, Japan
  • 2000-2003: PhD in Surgery from Wuhan University
  • 2003: Visiting Scholar at University of Miami, USA
  • 1987-1992: Resident in Urology, Hubei Provincial People's Hospital
  • 1992-1997: Attending Physician in Urology, Hubei Provincial People's Hospital
  • 1997-2002: Associate Chief Physician and Associate Professor in Urology, Renmin Hospital of Wuhan University
  • 2002-2003: Chief Physician and Associate Professor in Urology, Renmin Hospital of Wuhan University
  • 2003-Present: Chief Physician and Professor in Urology, Renmin Hospital of Wuhan University
  • 1991: Third Prize of Hubei Province Science and Technology Progress Award
  • 2001: Third Prize of Hubei Province Science and Technology Progress Award
  • 2004: Second Prize of Hubei Province Science and Technology Progress Award
  • 2019: Second Prize of Hubei Province Science and Technology Progress Award
Immunotherapy and gene therapy for prostate cancer
Immune tolerance in renal transplantation
  • Coptisine inhibits the malignancy of bladder carcinoma cells and regulates XPO1 expression, Li J, Liu X, 2023
  • Degradation of histone deacetylase 6 alleviates ROS-mediated apoptosis in renal ischemia-reperfusion injury, Xia K, Qiu T, Jian Y, Liu H, Chen H, Liu X, Chen Z, Wang L, 2023
  • Identification of disulfidptosis related subtypes, characterization of tumor microenvironment infiltration, and development of DRG prognostic prediction model in RCC, in which MSH3 is a key gene during disulfidptosis, Xu K, Zhang Y, Yan Z, Wang Y, Li Y, Qiu Q, Du Y, Chen Z, Liu X, 2023
  • A Weakly Supervised Deep Learning Model and Human-Machine Fusion for Accurate Grading of Renal Cell Carcinoma from Histopathology Slides, Zheng Q, Yang R, Xu H, Fan J, Jiao P, Ni X, Yuan J, Wang L, Chen Z, Liu X, 2023
  • DOT1L Epigenetically Regulates Autophagy and Mitochondria Fusion in Cell Lines of Renal Cancer, Hou Y, Liu J, Huang S, Wang L, Hu J, Liu X, 2023
  • Predicting Lymph Node Metastasis Status from Primary Muscle-Invasive Bladder Cancer Histology Slides Using Deep Learning: A Retrospective Multicenter Study, Zheng Q, Jian J, Wang J, Wang K, Fan J, Xu H, Ni X, Yang S, Yuan J, Wu J, Jiao P, Yang R, Chen Z, Liu X, Wang L, 2023
  • Cyanidin-3-O-glucoside plays a protective role against renal ischemia/reperfusion injury via the JAK/STAT pathway, Xiong Y, Jian J, Yu H, Wu J, Mao H, Feng R, Wang L, Jian Y, Liu X, 2023
  • Construction of cancer-associated fibroblasts related risk signature based on single-cell RNA-seq and bulk RNA-seq data in bladder urothelial carcinoma, Liu Y, Jian J, Zhang Y, Wang L, Liu X, Chen Z, 2023
  • Identification of essential genes and drug discovery in bladder cancer and inflammatory bowel disease via text mining and bioinformatics analysis, Zheng Q, Guo L, Yang R, Chen Z, Liu X, 2023
  • Development and validation of a deep-learning based assistance system for enhancing laparoscopic control level, Zheng Q, Yang R, Yang S, Ni X, Li Y, Jiang Z, Wang X, Wang L, Chen Z, Liu X, 2022
  • Lysine-specific demethylase 1 aggravated oxidative stress and ferroptosis induced by renal ischemia and reperfusion injury through activation of TLR4/NOX4 pathway in mice, Feng R, Xiong Y, Lei Y, Huang Q, Liu H, Zhao X, Chen Z, Chen H, Liu X, Wang L, Weng X, 2022
  • The LINC01929/miR-6875-5p/ADAMTS12 Axis in the ceRNA Network Regulates the Development of Advanced Bladder Cancer, Xiong Y, Pang M, Du Y, Yu X, Yuan J, Liu W, Wang L, Liu X, 2022
  • Fucoxanthin Attenuates Oxidative Damage by Activating the Sirt1/Nrf2/HO-1 Signaling Pathway to Protect the Kidney from Ischemia-Reperfusion Injury, Mao H, Wang L, Xiong Y, Jiang G, Liu X, 2022
  • Brusatol inhibits the growth of renal cell carcinoma by regulating the PTEN/PI3K/AKT pathway, Wang T, Chen Z, Chen H, Yu X, Wang L, Liu X, 2022
  • Knockdown of TRIM8 Protects HK-2 Cells Against Hypoxia/Reoxygenation-Induced Injury by Inhibiting Oxidative Stress-Mediated Apoptosis and Pyroptosis via PI3K/Akt Signal Pathway, Zhang BH, Liu H, Yuan Y, Weng XD, Du Y, Chen H, Chen ZY, Wang L, Liu XH, 2021
  • RCAN1.4 attenuates renal fibrosis through inhibiting calcineurin-mediated nuclear translocation of NFAT2, Zhang J, Chen H, Weng X, Liu H, Chen Z, Huang Q, Wang L, Liu X
  • The Suppression of Pin1-Alleviated Oxidative Stress through the p38 MAPK Pathway in Ischemia- and Reperfusion-Induced Acute Kidney Injury, Zhao X, Wang D, Wan S, Liu X, Wang W, Wang L, 2021
  • Modified completely intrafascial radical cysprostatectomy for bladder cancer: a single-center, blinded, controlled study, Wang X, Guo J, Wang L, Wang M, Weng X, Chen H, Liu X, 2021
  • The H3K9 histone methyltransferase G9a modulates renal ischemia reperfusion injury by targeting Sirt1, Liu H, Wang W, Weng X, Chen H, Chen Z, Du Y, Liu X, Wang L, 2021
  • LSD1 Promotes Prostate Cancer Cell Survival by Destabilizing FBXW7 at Post-Translational Level, Qin XK, Du Y, Liu XH, Wang L, 2021
Immunotherapy Gene Therapy Prostate Cancer Renal Transplantation Immune Tolerance Clinical Research Surgical Intervention Minimally Invasive Surgery Academic Leadership Medical Innovation

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.